Beginning in April 2013, physician-scientist Charles Sawyers will serve as President of the American Association for Cancer Research, the world’s oldest and largest professional organization dedicated to advancing cancer research.

Researchers have identified a set of genetic abnormalities that can enhance prognostic accuracy and aid treatment selection for people with acute myelogenous leukemia (AML).

Department of Surgery Chair Peter T. Scardino reflects on the expanding role of surgery at an institution devoted to caring for people with cancer.

Memorial Sloan-Kettering trains medical students, residents, and fellows to become leaders in cancer diagnosis and treatment.

Many cancers that develop in the mouth, nose, throat, and larynx can be cured. Watch this series to learn how our experts collaborate to give patients the best chance of a positive outcome.

When five-year-old CJ Postighone was diagnosed with a rare pediatric cancer called rhabdomyosarcoma, he came to Memorial Sloan-Kettering to receive a combination of surgery, chemotherapy, and radiation therapy.

The director of the Spine Tumor Center explains how this new, high-powered approach to radiation therapy has changed the way spine tumors are treated at Memorial Sloan-Kettering.